Archived Webcast

Medical Crossfire®: How The Experts Treat Acute Lymphoblastic Leukemia: Case Discussions from Adolescent to Adult

Release Date

December 10, 2022

Expiration Date

February 2, 2023

Credits

3 CME

Release Date: December 10, 2022

Expiration Date: February 1, 2023

Activity Overview

This educational activity is an archive of the live virtual presentation held on December 9, 2022.

For more information about this educational activity, the faculty, and disclosures, please click here.

Target Audience

This activity is directed toward medical oncologists, hematologic oncologists, hematologists, hematopathologists, nurses, and other healthcare professionals involved in the treatment of ALL.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Utilize cytogenetic and immunophenotype characteristics to create individualized treatment strategies for adults and pediatric patients with ALL
  • Assess the current and emerging role of MRD assessment in determining prognosis and in planning treatment in patients with ALL
  • Evaluate the efficacy and safety of current and emerging therapies including monoclonal antibodies, ADCs as well as CAR T-cell therapies in the management of patients with ALL
  • Place updated clinical trial data and evidence-based recommendations in the context of evolving management strategies utilizing antibody-based therapy in ALL management
Medical Crossfire®: How The Experts Treat Acute Lymphoblastic Leukemia: Case Discussions from Adolescent to Adult

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Educational Grant Support

This activity is supported by educational grants from Amgen, Inc., Jazz Pharmaceuticals, Inc., Syndax Pharmaceuticals, Inc, and Takeda Pharmaceuticals U.S.A., Inc.

Course

Medical Crossfire®: How The Experts Treat Acute Lymphoblastic Leukemia: Case Discussions from Adolescent to Adult

Create Account